TickerFacts.

Nomad Power Solutions, Inc. (NMAD): Total Liabilities

Annual figures by period end, from SEC filings.

$1.77M
As of 2025-12-31
$1.66M
As of 2026-06-30
2014-12-31: $273.4K2016-12-31: $218.7K2024-12-31: $318.3K2025-12-31: $1.77M$1.77M
2014-12-31 Total Liabilities (USD) 2025-12-31
Period endedTotal LiabilitiesChange YoYSource filing
2025-12-31$1.77M+456.8%2026-03-31, Balance as of period end
2024-12-31$318.3Kn/a2026-03-31, Balance as of period end
No annual figure between 2016-12-31 and 2024-12-31.
2016-12-31$218.7Kn/a2017-03-29, Balance as of period end
No annual figure between 2014-12-31 and 2016-12-31.
2014-12-31$273.4Kn/a2015-03-27, Balance as of period end

Total Liabilities at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal LiabilitiesChange YoY
Nomad Power Solutions, Inc. (NMAD)2025-12-31$1.77M+456.8%
Propanc Biopharma, Inc. (PPCB)2026-06-30$3.38M-41.0%
PMGC Holdings Inc. (ELAB)2025-12-31$5.03M+115.6%
NRX Pharmaceuticals, Inc. (NRXP)2025-12-31$28.89M+7.5%
Imunon, Inc. (IMNN)2025-12-31$5.23M-4.5%
Turn Therapeutics Inc. (TTRX)2025-12-31$7.48M+235.8%
Anebulo Pharmaceuticals, Inc. (ANEB)2025-06-30$487.7K+87.2%
PRF Technologies Ltd. (PRFX)2025-12-31$2.71M+0.3%
CalciMedica, Inc. (CALC)2025-12-31$20.23M+275.8%

Compare NMAD, PPCB, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗